© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 370,628 results that match your search.370,628 results
  • Colas has signed banks into a Eu450m five year revolver, increased from Eu400m after an oversubscription. BNP Paribas was bookrunner and Calyon was the other mandated lead arranger for the road construction and maintenance group.
  • The French government has announced the next stage in its privatisation programme with toll motorway operators SAPRR (Société des Autoroutes Paris-Rhin-Rhône) due to list this autumn and Sanef (Société des Autoroutes du Nord et de l?Est de la France) scheduled for the first half of 2005 .
  • Rating: Aaa/AAA
  • Guarantors: Gazexport Ltd, Gazprom OAO
  • Gazprom?s decision to push ahead with its securitisation of future gas exports was vindicated last Friday when it priced Russia?s first asset backed bond, having secured a book of $5.7bn.
  • Gazprom?s decision to push ahead with its securitisation of future gas exports was vindicated last Friday when it priced Russia?s first asset backed bond, having secured a book of $5.7bn.
  • Guarantor: GECC
  • German insurance company Gerling-Konzern is set to price its 20 year non-call 10 lower tier two capital offering today (Friday), after being forced to widen the spread from 250bp over Euribor to 275bp.
  • The Eu240m in debt supporting Investcorp?s buy-out of parking lot company Apcoa will not be launched until November. CIBC, Dresdner Kleinwort Wasserstein and Mizuho are underwriting the facilities.
  • Ghana Cocoa Board?s $700m facility has attracted over $1bn from the market. The borrower is considering taking a slight increase, but it is likely banks? allocations will be scaled back.
  • Equity sales on the London Stock Exchange delivered mixed messages this week, as e2v technologies made a successful debut and NeuTec Pharma executed a £25.8m secondary sale of shares on Aim ? but Radiancy and Cyclacel postponed their IPOs.